NRT Products Compared: The Patch Isn't the Best NRT

The standard NRT comparison treats the products as alternatives — pick the patch, or pick the gum, or pick the inhaler. That framing predates the strongest evidence in the field.

The actual finding from the cessation literature: combination NRT (long-acting + short-acting) outperforms any single-form NRT by roughly the same margin that single-form NRT outperforms placebo. The Cochrane meta-analysis pooled 27 trials and found combination roughly doubles 6-month sustained abstinence rates versus single NRT, with relative risk 1.34 (Lindson et al., Cochrane Database, 2019).

This means the meaningful comparison isn’t “which NRT product?” It’s “which combination?” and the right table to look at is the one above, with its “Combine With” column doing more work than the “Rating” column.

There is no “best NRT product.” There is a best NRT protocol.

Why combination is the empirical default

Single-form NRT addresses one of the two distinct problems in nicotine cessation:

1. Chronic withdrawal — slow background discomfort, irritability, low mood, sleep disruption. Best addressed by long-acting nicotine delivery (patch).
2. Breakthrough cravings — acute spikes triggered by specific contexts, lasting 3–5 minutes per wave. Best addressed by fast-onset nicotine delivery (gum, lozenge, inhaler, spray).

A patch alone leaves the breakthrough cravings unmedicated. Gum alone leaves the chronic withdrawal unmedicated. Combination addresses both.

The patch makes you a non-smoker on paper. Combination NRT addresses the rest.

This is why “single-form NRT” and “I tried the patch and it didn’t work for me” are common reports — and also why those reports usually reflect undertreatment rather than NRT failure.

How to actually combine

The two evidence-based default protocols:

Standard combination (most users):

• 21mg/24-hour patch as background, applied each morning
• 4mg gum or lozenge as needed for breakthrough cravings, up to 8–12 pieces/day
• Continued for 8–12 weeks before tapering

Heavy-smoker combination (>30 cig/day or strong dependence):

• 21mg patch + 4mg gum/lozenge as above
• Some clinicians add a second 14mg patch or use nasal spray for severe acute cravings (off-label, clinical supervision recommended)

The combination protocol roughly doubles 6-month abstinence rates compared to either component alone. The cost is modestly higher and the technique slightly more demanding (you have to remember to use the short-acting form when cravings hit).

What the table doesn’t show

The ratings in the comparison table reflect a balance of: cessation efficacy in trials, ease of use, side-effect profile, and availability. They don’t perfectly capture the most important practical variable, which is technique correctness.

Specifically:

• Nicotine gum delivers ~30% of its labeled dose if chewed continuously like regular gum. Correct technique is “chew until peppery taste, park between cheek and gum until taste fades, chew briefly again, repark.” Most users do this wrong.
• Acidic beverages (coffee, juice, soft drinks) within 15 minutes of gum or lozenge use significantly impair absorption.
• 24-hour patches cause vivid dreams in some users; switching to 16-hour patches usually solves this without losing efficacy.
• Nasal spray is the fastest-onset NRT but most users find the first week unpleasant. Pushing through gives the strongest acute craving control of any NRT.

For full dosing and technique detail, see NRT product reviews.

When NRT alone (combination or otherwise) isn’t enough

NRT — even correctly dosed and combined — averages 15–18% 6-month abstinence in heavy smokers. That’s a meaningful improvement over unaided quit rates (3–5%) but still leaves most users relapsing within six months.

The main alternatives where data is stronger than NRT alone:

• Varenicline: ~18–22% 6-month abstinence as monotherapy; up to ~30% with behavioral support.
• Combination pharmacotherapy: varenicline + NRT in some clinical settings.
• E-cigarettes: ~18% in Hajek 2019 NEJM trial; controversial but data is real.
• Cytisine: outperformed NRT in head-to-head trials; minimal availability in Western markets.

For the broader method comparison, see quitting methods compared.

Practical decision

If you’re a moderate-to-heavy smoker and you haven’t tried NRT before:

• Start with combination NRT (21mg patch + 4mg gum or lozenge), correctly dosed and used with proper technique, for 8–12 weeks.
• Layer behavioral support — at minimum a tracking app with structured craving logging. Cessation tools improve outcomes modestly but consistently (Whittaker et al., Cochrane, 2019).
• Plan for day 3 and week 3 specifically — these are the two relapse peaks.

If you’ve tried single-form NRT before and concluded it doesn’t work:

• The most likely failure mode is undertreatment or technique error, not NRT inefficacy. Try correctly-dosed combination NRT before moving to varenicline.

If you’ve tried correctly-dosed combination NRT and it didn’t work:

• Varenicline + behavioral support is the next evidence-based step.

Related guides

• NRT product reviews — detailed dosing, technique, and product-specific guidance.
• Quitting methods compared — where NRT fits in the broader method landscape.
• Cravings and triggers — the behavioral side of breakthrough craving management.
• How to quit smoking cold turkey — why “cold turkey” and “with NRT” aren’t mutually exclusive.

Disclosure: some product links on this site are affiliate links. We only recommend NRT products with strong evidence behind them. See our privacy policy for full disclosure.

The headline data, restated

Roughly:

• Unaided quit attempts: 3–5% sustained at 6 months
• Single-form NRT (patch alone): 7–11%
• Combination NRT (patch + gum/lozenge): 15–18%
• Varenicline alone: 18–22%
• Combination NRT + behavioral support: 20–28%
• Varenicline + behavioral support: 25–30%

The single biggest jump in the chain is from single-form to combination NRT. That’s the one most quit-smoking content underemphasizes.

If you smoked through the patch, the patch wasn’t enough. That’s the dose, not the drug.